Telisotuzumab vedotin-tllv
(tel-EYE-soe-TOOZ-ue-mab ve-DOE-tin)
This page contains brief information about telisotuzumab vedotin-tllv and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.
US Brand Name(s)
Emrelis
FDA Approved
Yes
FDA label information for this drug is available at DailyMed.
Use in Cancer
Telisotuzumab vedotin-tllv is approved to be used alone or with other drugs to treat:
- Non-small cell lung cancer (certain types).
More About Telisotuzumab Vedotin-tllv
Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.
MedlinePlus Information on Telisotuzumab Vedotin-tllv - A lay language summary of important information about this drug.
Research Results and Related Resources
Targeted Therapy to Treat Cancer
Clinical Trials Accepting Patients
Find Clinical Trials for Telisotuzumab Vedotin-tllv - Check for trials now accepting patients.